Skip to main content

Table 3 Multivariate analysis of prognostic factors of BC

From: Downregulated ZNF132 predicts unfavorable outcomes in breast Cancer via Hypermethylation modification

Variable

Hazard ratio

95%CI

P-value

Age(>60/≤60)

2.278

(1.453,3.571)

0.000

HER2(Positive / Negative)

0.804

(0.405,1.597)

0.533

ER(Positive/Negative)

1.015

(0.507,2.032)

0.966

PR(Positive/Negative)

0.618

(0.330,1.154)

0.131

Tumor size(T2-T4/T1)

1.238

(0.548,2.800)

0.608

Lymph Node metastasis(Yes/No)

1.630

(0.959,2.770)

0.071

Distant metastasis(Yes/No)

3.427

(1.665,7.055)

0.001

Clinical stage(II-IV/I)

1.140

(0.386,3.369)

0.813

ZNF132 expression(High/Low)

1.129

(0.728,1.753)

0.587